Clinical trial Recruiting at 2 sites Interventional Ages 18 to 70

VR program to improve social functioning for people with substance use and mental health disorders

Official title: Improving Social Functioning in People With Substance Use and Mental Health Disorders Using Virtual Reality (ROPVR): Study Protocol for a Multi-centre, Pragmatic Randomized Controlled Trial

Run by Sykehuset Innlandet HF · NCT06677515 · Data updated 2026-11-12

This trial will try a virtual reality (VR) training program to see if it helps adults in long-term addiction treatment who also have mental health problems improve social and practical functioning.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment102 (estimated)
SponsorSykehuset Innlandet HF
Academic / other
Locations2 sites (Brumunddal and 1 other locations)
StatusRecruiting
StartedMay 8, 2025
Main results expectedJune 2026
Study endsDecember 2026
Registry record updatedJanuary 23, 2026
Trial IDNCT06677515 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) receiving in-patient substance use disorder treatment in specialized addiction units in South-East Norway who can read Norwegian, give informed consent, and are willing and able to attend VR sessions twice weekly for five weeks are eligible.

Probably not a fit

People with significant visual, auditory, or balance impairments, epilepsy or other conditions that make VR unsafe, current acute psychosis or active suicidal plans, or severe simulation sickness are unlikely to qualify or benefit from the VR training.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multi-centre, pragmatic randomized controlled trial comparing a VR-training program with treatment as usual among adults receiving in-patient addiction treatment in South-East Norway. Participants will be randomized to receive twice-weekly VR training sessions for five weeks or continue usual care, with outcomes measured from baseline to six months. Primary outcomes include resilience, quality of life, practical and social functioning, and social participation, and the trial will also analyze cost-effectiveness of the VR program. The VR intervention was developed in prior exploratory and development work and is now being tested in this larger effectiveness trial.

Why it matters

Potential benefit: If successful, the VR training could improve resilience, quality of life, daily social skills, and community participation for people in long-term addiction treatment and may be a cost-effective addition to care.

How similar studies have gone: The VR program was developed after prior exploratory and development studies and VR interventions for mental health and substance use have shown promise in smaller trials, but large pragmatic RCT evidence remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* adults aged 18 years or older receiving in-patient SUD treatment in specialized addiction treatment units in South-East Norway. This may include persons serving prison sentences during in-patient treatment according to the Execution of Sentences Act in Norway
* having the capability to read, understand and sign the Norwegian informed consent form
* willing and able to attend VR training two times a week for 5 weeks

Exclusion Criteria:

* significant visual, auditory, or balance impairment or other diseases affecting safety during VR sessions (e.g., epilepsy)
* current clinically significant severe mental health disorder (e.g., acute episode of psychosis or current active suicidal plans). Persons with psychotic disorders or other severe mental illness are not excluded if their condition is stable.
* severe travel sickness as a proxy for simulation sickness

Where it's running

  • Innlandet Hospital Trust
    Brumunddal, Norway
    Recruiting
  • Sykehuset Innlandet HF
    Hamar, Norway
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.